Globus Medical, Inc.
GMED
Rang in Aktien
#1980
Globus Medical, Inc. is a global medical technology company dedicated to... Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
Aktienkurs
$79.05
Marktkapitalisierung
$10.61B
Veränderung (1 Tag)
4.29%
Veränderung (1 Jahr)
28.37%
Land
US
Handel Globus Medical, Inc. (GMED)
Kategorie
Healthcare
Gewinn für Globus Medical, Inc. (GMED)
Gewinn im Jun 2026 TTM: $664.95M
Laut den aktuellen Finanzberichten von Globus Medical, Inc. betragen die aktuellen Gewinne des Unternehmens $664.95M. Im Jahr 2023 erzielte das Unternehmen einen Gewinn von $165.39M, ein Rückgang im Vergleich zu dem Gewinn im Jahr 2022, der $243.02M betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Globus Medical, Inc. von 2009 bis 2026
Gewinn am Ende jedes Jahres
| Jahr | Gewinn | ändert |
|---|---|---|
| 2026 (TTM) | $664.95M | 450.81% |
| 2024 | $120.72M | -27.01% |
| 2023 | $165.39M | -31.94% |
| 2022 | $243.02M | 34.71% |
| 2021 | $180.41M | 43.30% |
| 2020 | $125.90M | -33.72% |
| 2019 | $189.95M | 0.71% |
| 2018 | $188.61M | 10.99% |
| 2017 | $169.93M | 8.04% |
| 2016 | $157.28M | -8.98% |
| 2015 | $172.81M | 24.64% |
| 2014 | $138.64M | 35.92% |
| 2013 | $102.00M | -11.04% |
| 2012 | $114.65M | 18.26% |
| 2011 | $96.95M | 10.50% |
| 2010 | $87.74M | 7.29% |
| 2009 | $81.78M | 0.00% |
Gewinn ähnlicher Unternehmen oder Konkurrenten
| Unternehmen | Gewinn | Gewinnunterschied | Land |
|---|---|---|---|
| $7.51B | 1,029.56% |
US
|
|
| $5.56B | 736.60% |
IE
|
|
| $5.15B | 674.19% |
US
|
|
| $3.86B | 480.65% |
US
|
|
| - | - |
DE
|
